Correction: Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study

Barbara Kollerits¹, Simon Gruber¹, Inga Steinbrenner², Johannes P Schwaiger¹, Hansi Weissensteiner¹, Sebastian Schönherr¹, Lukas Forer¹, Fruzsina Kotsis^{2

3}, Ulla T Schultheiss^{2

3}, Heike Meiselbach^{4

5}, Christoph Wanner⁶, Kai-Uwe Eckardt^{4

5

7}, Florian Kronenberg⁸; GCKD Investigators

Affiliations

¹ Institute of Genetic Epidemiology, Medical University of Innsbruck, Schöpfstraße 41, 6020, Innsbruck, Austria.
² Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center - University of Freiburg, Freiburg, Germany.
³ Department of Medicine IV - Nephrology and Primary Care, Faculty of Medicine and Medical Center - , University of Freiburg, Freiburg, Germany.
⁴ Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
⁵ German Chronic Kidney Disease Study, Erlangen, Germany.
⁶ Division of Nephrology, Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany.
⁷ Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany.
⁸ Institute of Genetic Epidemiology, Medical University of Innsbruck, Schöpfstraße 41, 6020, Innsbruck, Austria. Florian.Kronenberg@i-med.ac.at.

Published Erratum

Barbara Kollerits et al. BMC Cancer. 2024.

. 2024 Mar 19;24(1):348.

doi: 10.1186/s12885-024-12128-6.

¹ Institute of Genetic Epidemiology, Medical University of Innsbruck, Schöpfstraße 41, 6020, Innsbruck, Austria.
² Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center - University of Freiburg, Freiburg, Germany.
³ Department of Medicine IV - Nephrology and Primary Care, Faculty of Medicine and Medical Center - , University of Freiburg, Freiburg, Germany.
⁴ Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
⁵ German Chronic Kidney Disease Study, Erlangen, Germany.
⁶ Division of Nephrology, Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany.
⁷ Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany.
⁸ Institute of Genetic Epidemiology, Medical University of Innsbruck, Schöpfstraße 41, 6020, Innsbruck, Austria. Florian.Kronenberg@i-med.ac.at.

No abstract available

Erratum for

Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study.
Kollerits B, Gruber S, Steinbrenner I, Schwaiger JP, Weissensteiner H, Schönherr S, Forer L, Kotsis F, Schultheiss UT, Meiselbach H, Wanner C, Eckardt KU, Kronenberg F; GCKD Investigators. Kollerits B, et al. BMC Cancer. 2024 Mar 7;24(1):320. doi: 10.1186/s12885-024-12053-8. BMC Cancer. 2024. PMID: 38454416 Free PMC article.

1. Kollerits B, Gruber S, Steinbrenner I, et al. Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study. BMC Cancer. 2024;24:320. doi: 10.1186/s12885-024-12053-8. - DOI - PMC - PubMed